Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
CatSci
CatSci
Activities:
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
CatSci acquires Reach Separations to offer end-to-end chiral separation
The acquisition boosts CatSci's chromatography offering and diversifies its services to customers in manufacturing
CatSci wins Welsh government SMART Capital Equipment Grant for oligonucleotide development
CatSci has won a Welsh Government SMART Capital Equipment Fund grant to enhance their oligonucleotides capability and offer more and better R&D and manufacturing solutions to customers
Analysis
CatSci expands capabilities to offer expert cGMP analytical development services
CatSci is thrilled to announce the launch of its expert cGMP analytical capabilities in Dagenham, UK
Manufacturing
Catsci welcomes His Majesty’s Lord-Lieutenant in Wales
This special visit was to commemorate CatSci’s monumental achievement in winning The Queen’s Award for Enterprise: International Trade 2022
Manufacturing
CatSci's new partnership with AGC Pharma Chemicals
AGC Pharma Chemicals have more than 40 years of small molecule CDMO and 60 years of API manufacturing experienc
Manufacturing
CatSci invests in oligonucleotides production capability
Oligonucleotides are an emerging modality and an innovative technology offering new therapeutics opportunities to treat previously unmet patients’ needs
Manufacturing
CatSci wins at Bionow Awards
“We are dedicated to continually evolving to support pharmaceutical companies all over the globe and address their CMC demands”
Subscribe now